Surgical Pathology Cancer Case Summary
NON-HODGKIN’S LYMPHOMA: Report
Surgical Pathology Cancer Case Summary
NON-HODGKIN’S LYMPHOMA: Biopsy/Resection
MACROSCOPIC (check all that apply)
SPECIMEN TYPE
__ Lymphadenectomy
__ Other (specify: __________________)
TUMOR SITE:
__ Lymph Node(s)
__ Site unknown
Site:__________________________
Site:__________________________
Site:__________________________
__ Other tissue(s) or organ(s)* (see separate organ protocols, if applicable)
Site:__________________________
Site:__________________________
Site:__________________________
* non-gastrointestinal site (for primary gastrointestinal lymphoma, see
Gastrointestinal Lymphoma protocol)
TUMOR SIZE (Largest single mass)
__ x __ x ___ cm (site:________________)
MICROSCOPIC (check all that apply)
IMMUNOPHENOTYPING
___ Performed (see COMMENT, if pertinent)
___ Not performed
HISTOLOGIC TYPE (Revised European-American Lymphoma [REAL] Classification)
___ B cell lymphoma
___ Subtype cannot be determined
___ Precursor B-lymphoblastic lymphoma/leukemia
___ B-cell chronic lymphocytic leukemia/prolymphocytic leukemia/small lymphocytic lymphoma
___ Mantle cell lymphoma
___ Lymphoplasmacytic/immunocytoma
___ Follicle center lymphoma
___ Follicular Grade I
___ Follicular Grade II
___ Follicular Grade III
___ Diffuse predominantly small cell
___ Extranodal marginal zone B-cell lymphoma (low grade B-cell lymphoma of MALT type)
___ Nodal marginal zone B-cell lymphoma (monocytoid B-cell lymphoma)
___ Splenic marginal zone B-cell lymphoma
___ Hairy cell leukemia
___ Plasmacytoma/plasma cell myeloma
___ Diffuse large B-cell lymphoma
___ Primary mediastinal B-cell lymphoma
___ Burkitt’s lymphoma
___ High grade B-cell lymphoma, Burkitt-like
___ T cell lymphoma
___ Subtype cannot be determined
___ Precursor T-lymphoblastic lymphoma/leukemia
___ T-cell chronic lymphocytic leukemia/prolymphocytic leukemia
___ Large granular lymphocytic leukemia
___ T-cell type
___ NK-cell type
___ Peripheral T-cell lymphomas, unspecified
___ Hepatosplenic g-d T-cell lymphoma
___ Angioimmunoblastic T-cell lymphoma
___ Nasal / nasal type T/NK cell (angiocentric) lymphoma
___ Adult T-cell lymphoma/leukemia
___ Anaplastic large cell lymphoma
___ T-cell type
___ Null cell type
EXTENT OF TUMOR
___ Cannot be assessed
___ Stage I
___ Involvement of a single lymph node region
(specify site: _________________________)
or
___ Localized involvement of a single extralymphatic organ or site
(specify site: _________________________________)
___ Stage II
___ Involvement of two or more lymph node regions on the same side of the diaphragm
or
___ Localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm
___ Stage III: Involvement of lymph node regions on both sides of the diaphragm
with (check those that apply):
___ Localized involvement of an extralymphatic organ or site present
(specify site: _________________________)
___ Involvement of an extralymphatic organ or site-unknown
___ Involvement of the spleen present
___ Involvement of the spleen-unknown
___ Stage IV: Disseminated (multifocal) involvement of one or more extralymphatic organs (specify site(s): __________________________) with (check those that apply):
___ Associated lymph node involvement present
___ Associated lymph node involvement unknown
___ Distant (nonregional) nodal involvement present
ADDITIONAL PATHOLOGIC FINDINGS
Specify: _____________________________________
_____________________________________________
_____________________________________________
_____________________________________________
COMMENT
_____________________________________________
_____________________________________________
_____________________________________________
_____________________________________________
_____________________________________________